Shandong Weigao Group Medical Polymer Company Limited SHWGF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 503.24M | 494.46M | 475.73M | 471.18M | 459.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 503.24M | 494.46M | 475.73M | 471.18M | 459.42M |
| Cost of Revenue | 270.27M | 265.56M | 262.46M | 259.95M | 230.99M |
| Gross Profit | 232.97M | 228.91M | 213.27M | 211.23M | 228.43M |
| SG&A Expenses | 127.78M | 125.55M | 142.62M | 141.26M | 124.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 420.25M | 412.93M | 428.43M | 424.33M | 378.12M |
| Operating Income | 82.98M | 81.54M | 47.30M | 46.84M | 81.30M |
| Income Before Tax | 75.86M | 74.54M | 56.82M | 56.28M | 84.77M |
| Income Tax Expenses | 15.62M | 15.35M | 10.71M | 10.61M | 11.68M |
| Earnings from Continuing Operations | 60.24M | 59.19M | 46.11M | 45.67M | 73.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.36M | -3.30M | -3.51M | -3.48M | -3.37M |
| Net Income | 56.88M | 55.89M | 42.59M | 42.19M | 69.72M |
| EBIT | 82.98M | 81.54M | 47.30M | 46.84M | 81.30M |
| EBITDA | 118.48M | 116.41M | 78.58M | 77.83M | 113.29M |
| EPS Basic | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 4.52B | 4.52B | 4.53B | 4.53B | 4.54B |
| Average Diluted Shares Outstanding | 4.52B | 4.52B | 4.53B | 4.53B | 4.54B |
| Dividend Per Share | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Payout Ratio | -- | -- | 164.02% | 164.02% | -- |